BriaCell Therapeutics (SBIR)
Funding Details
Awarder
HHS NIH
Date Award
September 1, 2023
Vertical
Biotechnology Research
Funding URL
View Funding Page
Funding Amount
$399,918
Company Info
Company Description

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Biotechnology Research DealsView Funding Announcement